Crossmark

Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1038/s41417-023-00593-3

Published Online: 2023-02-07

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elsallab, Magdi

Ellithi, Moataz https://orcid.org/0000-0002-6261-4898
Hempel, Susanne

Abdel-Azim, Hisham

Abou-el-Enein, Mohamed https://orcid.org/0000-0003-2903-9040
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute
License Information

Text and Data Mining valid from 2023-02-07

Version of Record valid from 2023-02-07
More Information

Article History

Received: 25 November 2022

Revised: 14 December 2022

Accepted: 19 January 2023

First Online: 7 February 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below